IBM 2991 Blood Cell Processor Mod. 1 & 2
510(k) K812355
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK812355 | Date9 Sep 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CAC
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.5830
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The IBM 2991 Blood Cell Processor Mod. 1 & 2 is an Apparatus, Autotransfusion designed for the automated washing and separation of blood cells. It is specifically intended for removing glycerol preservatives from frozen and thawed red blood cells, facilitating safer and more stable storage for transfusion purposes. This device supports blood processing procedures by mechanically separating cellular components from plasma and glycerol, ensuring compatibility for clinical use.
This device is supplied as a reusable medical instrument and is classified under FDA regulation 868.5830 as a Class II device. It was granted FDA 510K clearance (K812355) in 1981, with the submission reviewed by the Anesthesiology Advisory Committee. The processor operates in clinical settings, such as blood banks and transfusion centers, and requires proper maintenance and sterilization between uses. No MRI safety information is provided in the specifications.